A Cost Benefit Analysis - Bilateral Infraclavicular Nerve Block: Single Injection Liposomal Bupivacaine Vs Bupivacaine HCl with Epinephrine and Dexamethasone

##plugins.themes.bootstrap3.article.main##

Jurcik Charlota, MD
Department of Anesthesiology, Rutgers NJMS, Newark, NJ, USA

Iannaccone, Ferdinand, DO
Department of Anesthesiology, Rutgers NJMS, Newark, NJ, USA

Eloy, Jean Daniel, MD
Department of Anesthesiology, Rutgers NJMS, Newark, NJ, USA

Keywords

Abstract

According to the CDC there were roughly 671,000 fracture reductions performed on inpatients in 2010

Downloads

Download data is not yet available.

Article Metrics Graph

Chart Graph | Range Graph
Abstract 274 | PDF Downloads 129 XML Downloads 37 HTML Downloads 28 ePub Downloads 56

##plugins.themes.bootstrap3.article.sidebar##

Downloads
PDF XML HTML ePub
Published
Jun 22, 2020
DOI:10.15520/ijcrr.v11i06.815

##plugins.themes.bootstrap3.article.details##

How to Cite
Charlota, MD, J. ., Ferdinand, DO, I. ., & Daniel, MD , E. J. . (2020). A Cost Benefit Analysis - Bilateral Infraclavicular Nerve Block: Single Injection Liposomal Bupivacaine Vs Bupivacaine HCl with Epinephrine and Dexamethasone. International Journal of Contemporary Research and Review, 11(06), 20789–20793. https://doi.org/10.15520/ijcrr.v11i06.815
Issue
Vol. 11 No. 06 (2020)
Section
Medical Science